Clinical Trial Update: Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a fenofibrate/metformin fixed-dose combination versus metformin alone in patients with dyslipidemia and glucose metabolism disorders; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Glucose Metabolism Disorders

Drugs mentioned

• Fenofibrate/metformin fixed-dose combination
• metformin (metformin)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Dyslipidemia/Glucose Metabolism Disorder | Phase 3 | Status: COMPLETED